Skip to main content
. 2014 Sep 25;9:1021–1031. doi: 10.2147/COPD.S58258

Figure 1.

Figure 1

Percentage of new users of LABD receiving the same treatment at the index date at specified time intervals (n=3,268).

Notes: Patients had not received inhaled corticosteroids at the LABD index date or during the 12-month prior history. The percentage receiving treatment at the index date was 100% for all patients because they were all new users of LABD.

Abbreviations: LABA, long-acting β2-agonist; LABD, long-acting bronchodilator; LAMA, long-acting muscarinic antagonist.